About grifols sa - GRFS
Grifols SA is a global specialty plasma therapeutics company that engages in the development, manufacturing, and distribution of a broad range of biological medicines based on plasma-derived proteins. It operates through the following segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma Segment includes all activities related with products deriving from human plasma for therapeutic use. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols i Roig in 1909 and is headquartered in Barcelona, Spain.
GRFS At a Glance
Grifols SA
Avinguda de la Generalitat, 152-158
Barcelona, Catalonia 08174
| Phone | 34-93-571-22-00 | Revenue | 8.49B | |
| Industry | Pharmaceuticals: Major | Net Income | 453.69M | |
| Sector | Health Technology | 2025 Sales Growth | 8.843% | |
| Fiscal Year-end | 12 / 2026 | Employees | 25,258 | |
| View SEC Filings |
GRFS Valuation
| P/E Current | 12.361 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 14.026 |
| Price to Sales Ratio | 0.749 |
| Price to Book Ratio | 1.028 |
| Price to Cash Flow Ratio | 5.39 |
| Enterprise Value to EBITDA | 9.671 |
| Enterprise Value to Sales | 2.167 |
| Total Debt to Enterprise Value | 0.558 |
GRFS Efficiency
| Revenue/Employee | 336,187.366 |
| Income Per Employee | 17,962.164 |
| Receivables Turnover | 8.556 |
| Total Asset Turnover | 0.374 |
GRFS Liquidity
| Current Ratio | 2.513 |
| Quick Ratio | 0.881 |
| Cash Ratio | 0.409 |
GRFS Profitability
| Gross Margin | 35.699 |
| Operating Margin | 16.427 |
| Pretax Margin | 8.28 |
| Net Margin | 5.343 |
| Return on Assets | 1.999 |
| Return on Equity | 7.387 |
| Return on Total Capital | 2.756 |
| Return on Invested Capital | 2.919 |
GRFS Capital Structure
| Total Debt to Total Equity | 165.889 |
| Total Debt to Total Capital | 62.39 |
| Total Debt to Total Assets | 44.255 |
| Long-Term Debt to Equity | 158.566 |
| Long-Term Debt to Total Capital | 59.636 |